High Positive Predictive Value (PPV) of Cell-Free DNA (cfDNA) Testing in a Clinical Study of 10,000 Consecutive Pregnancies

Autor: Vercammen E, Zamani T, Poeschmann P, Que Dg, Stoica S, Dierickx H, van Rheenen-Flach Le, IliÄ M, Vanparijs P, Ldrissi M, man H, Weber B, Schotten J, Nuradi W, Engelen P, Jochems L, DeBoulle K, De Baets Ggd, Klaassen B, Bekedam D, Dewulf M, KorÅejeva L, Muyldermans K, Coenen M, Bouwens G, Valkenburg Mh, Janssens P, Mestdach F, Topalov D, Wildschut H, Machtelinckx L, Rijnders R, Bovyn T, Albertyn P, Van den Bosch G, Vlaemynck G, Engelen Mc, De Spiegeleer S, BenušienÄ E, Witters K, Top W, Six S, Verschueren S, Martens S, Smet D, Coppens H, Anttonen Ak, Segers N, Badura-Stronka M, Vereecken A, Crnogorac IliÄ Z, Gaugler Senden I, Malniece I, Militaru M, Van Wijngaarden W, Deweert S, Wuyts Km, De Puydt H, Janssens Pm, enakker Es, Castenmiller C, Brezigar A, Momirovska A, Kuyken E, Spiritus T, Vulic R, Willems Pj, Boekweit L, Catry, Culic, Grinfelde I

Publikováno v: Journal of molecular biomarkers & diagnosis, Los Angeles : OMICS Publishing Group, 2016, Vol. 7, no3, art. no 285 [p. 1-7]

Background: Cell-free DNA (cfDNA) analysis in maternal blood for the detection of fetal Down syndrome is gradually replacing first trimester screening. We present here a large clinical series of 10,000 consecutive pregnancies. Objectives: To study th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5888d2fc2f7693909ea8dcc5c523befe
https://doi.org/10.4172/2155-9929.1000285